Chromatin/Epigenetics
Read More about this categoryShow Less
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
Research Areas
- Bromodomain(44)
- Aurora Kinase(68)
- DNA Methyltransferase(41)
- HDAC(230)
- Histone Acetyltransferases(90)
- Histone Demethylases(110)
- Histone Methyltransferase(258)
- HIF(118)
- JAK(169)
- MBT Domains
- PARP(147)
- Pim(32)
- Protein Ser/Thr Phosphatases(23)
- RNA Polymerase(4)
- Sirtuin(80)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(20)
- Epigenetic Reader Domain(269)
- MicroRNA(29)
- Protein Arginine Deiminase(15)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(43)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(14)
- METTL3(4)
- WDR5(3)
- TET Protein(2)
- HuR(1)
- SF3B1(2)
Products Related to Chromatin/Epigenetics(1791)
- GC80919AURKA-IN-4CAS: 89575-11-1Purity: >99.50%
AURKA-IN-4 is a Capsaicin -derived molecular glue targeting AURKA-PHB2, and acts as an inhibitor of Aurora kinase A ( AURKA ) and PHB2.
- GC80920PROTAC PARP2 degrader-1CAS: 2925182-32-5Purity: >95.50%
PROTAC PARP2 degrader-1 is an orally active PARP2 PROTAC degrader with a DC 50 of 2 μM.
- GC80922PROTAC HDAC6 degrader 7Purity: >98%
PROTAC HDAC6 degrader 7 is an orally active, highly efficient, and selective PROTAC degrader targeting histone deacetylase 6 ( HDAC6 ) ( IC 50 = 118 nM).
- GC80923PROTAC HDAC degrader-2 TFAPurity: >96.50%
PROTAC HDAC degrader-2 TFA is a selective class IIb dual histone deacetylase ( HDAC6 and HDAC10 ) PROTAC degrader, with DC 50 values of 13 nM and 29 nM against HDAC6 and HDAC10, respectively.
- GC80924iVeliparib-AP6CAS: 2472645-27-3Purity: >98%
iVeliparib-AP6 is a proteolysis-targeting chimera ( PROTAC ) molecule designed based on Veliparib, which targets PARP1/2.
- GC80925KAT2A/B ligand 1CAS: 2254066-18-5Purity: >99.00%
KAT2A/B ligand 1 (compound 32a) is a KAT2A/B ligand.
- GC80926BI-7273 acidCAS: 2097514-90-2Purity: >98.00%
BI-7273 acid, BI-7273 derivative, is a BRD9 PROTAC ligand.
- GC80927NSD2 ligand 2CAS: 3031353-62-2Purity: >98.50%
NSD2 ligand 2 is a ligand for target protein for PROTAC that specifically binds to NSD2.
- GC80930DNMT1 Degrader-1CAS: 2962943-72-0Purity: >99.00%
DNMT1 Degrader-1 is a selective DNMT1 degrader with an IC 50 of 202.87 nM and a Kd value of 122 nM.
- GC80934PROTAC BRD4 Degrader-49CAS: 3115940-40-1Purity: >98%
BRD4 degrader-8 is a BRD4 -targeting degrader.
- GC80936PROTAC BLIMP-1 degrader-1Purity: >98.00%
PROTAC BLIMP-1 degrader-1 is an orally active BLIMP-1 PROTAC degrader with an EC 50 of 13.1 nM.
- GC80937PROTAC KAT6 Degrader-1Purity: >98%
PROTAC KAT6 Degrader-1 is a CRBN-dependented KAT6 PROTAC degrader.
- GC80946PROTAC JAK1/2 degrader-1Purity: >99.00%
PROTAC JAK1/2 degrader-1 is an orally active JAK1 / JAK2 PROTAC degrader, with DC 50 values of 1.4 μM and 0.92 μM against JAK1 and JAK2, respectively.
- GC80947JAK1/2 ligand 1CAS: 1026028-96-5Purity: >99.50%
JAK1/2 ligand 1 is a ligand for the PROTAC target protein of JAK1/2, which can be used to synthesize PROTAC JAK1/2 degrader-1.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC80918 | dCBP-30 | - | >98% | |
dCBP-30 is an orally active, selective and dual-acting CBP/p300 PROTAC degrader with DC 50 values of 0.05 nM (CBP) and 0.04 nM (p300), respectively. | ||||
| GC80919 | AURKA-IN-4 | 89575-11-1 | >99.50% | |
AURKA-IN-4 is a Capsaicin -derived molecular glue targeting AURKA-PHB2, and acts as an inhibitor of Aurora kinase A ( AURKA ) and PHB2. | ||||
| GC80920 | PROTAC PARP2 degrader-1 | 2925182-32-5 | >95.50% | |
PROTAC PARP2 degrader-1 is an orally active PARP2 PROTAC degrader with a DC 50 of 2 μM. | ||||
| GC80921 | CCT400028 | - | >98.00% | |
CCT400028 is a PROTACs -class degrader that targets the Aurora A (AURKA) kinase. | ||||
| GC80922 | PROTAC HDAC6 degrader 7 | - | >98% | |
PROTAC HDAC6 degrader 7 is an orally active, highly efficient, and selective PROTAC degrader targeting histone deacetylase 6 ( HDAC6 ) ( IC 50 = 118 nM). | ||||
| GC80923 | PROTAC HDAC degrader-2 TFA | - | >96.50% | |
PROTAC HDAC degrader-2 TFA is a selective class IIb dual histone deacetylase ( HDAC6 and HDAC10 ) PROTAC degrader, with DC 50 values of 13 nM and 29 nM against HDAC6 and HDAC10, respectively. | ||||
| GC80924 | iVeliparib-AP6 | 2472645-27-3 | >98% | |
iVeliparib-AP6 is a proteolysis-targeting chimera ( PROTAC ) molecule designed based on Veliparib, which targets PARP1/2. | ||||
| GC80925 | KAT2A/B ligand 1 | 2254066-18-5 | >99.00% | |
KAT2A/B ligand 1 (compound 32a) is a KAT2A/B ligand. | ||||
| GC80926 | BI-7273 acid | 2097514-90-2 | >98.00% | |
BI-7273 acid, BI-7273 derivative, is a BRD9 PROTAC ligand. | ||||
| GC80927 | NSD2 ligand 2 | 3031353-62-2 | >98.50% | |
NSD2 ligand 2 is a ligand for target protein for PROTAC that specifically binds to NSD2. | ||||
| GC80928 | NP1192 | 2966791-41-1 | >99.00% | |
NP1192 is a potent, selective PROTAC NAT10 degrader. | ||||
| GC80929 | PLX-4104 | 2851986-77-9 | >98% | |
PLX-4104 is an orally active BRD4 molecular glue degrader with a DC 50 of 2 nM. | ||||
| GC80930 | DNMT1 Degrader-1 | 2962943-72-0 | >99.00% | |
DNMT1 Degrader-1 is a selective DNMT1 degrader with an IC 50 of 202.87 nM and a Kd value of 122 nM. | ||||
| GC80931 | dHTC3 | - | >98% | |
dHTC3 is a selective BRD4 molecular glue degrader. | ||||
| GC80932 | UNC10088 | - | >98% | |
UNC10088 is a molecular glue targeting NSD2. | ||||
| GC80933 | AMX-883 | 3102636-19-8 | >98% | |
AMX-883 a selective and orally active BRD9 molecular glue degrader that drives differentiation in acute myeloid leukaemia. | ||||
| GC80934 | PROTAC BRD4 Degrader-49 | 3115940-40-1 | >98% | |
BRD4 degrader-8 is a BRD4 -targeting degrader. | ||||
| GC80935 | JQ1-JX5 | - | >98% | |
JQ1-JX5 is a DCAF16-based BRD4 PROTAC degrader. | ||||
| GC80936 | PROTAC BLIMP-1 degrader-1 | - | >98.00% | |
PROTAC BLIMP-1 degrader-1 is an orally active BLIMP-1 PROTAC degrader with an EC 50 of 13.1 nM. | ||||
| GC80937 | PROTAC KAT6 Degrader-1 | - | >98% | |
PROTAC KAT6 Degrader-1 is a CRBN-dependented KAT6 PROTAC degrader. | ||||
| GC80938 | DOT1L808 | - | >98.00% | |
DOT1L808 is a potent and highly selective DOT1L PROTAC degrader with a DC 50 value of 5 nM. | ||||
| GC80939 | MS115 TFA | 3109377-61-6 | >98.00% | |
MS115 TFA is a selective PRMT5/MEP50 PROTAC degrader, with DC 50 values of 17.4 nM and 11.3 nM for PRMT5 and MEP50, respectively. | ||||
| GC80946 | PROTAC JAK1/2 degrader-1 | - | >99.00% | |
PROTAC JAK1/2 degrader-1 is an orally active JAK1 / JAK2 PROTAC degrader, with DC 50 values of 1.4 μM and 0.92 μM against JAK1 and JAK2, respectively. | ||||
| GC80947 | JAK1/2 ligand 1 | 1026028-96-5 | >99.50% | |
JAK1/2 ligand 1 is a ligand for the PROTAC target protein of JAK1/2, which can be used to synthesize PROTAC JAK1/2 degrader-1. | ||||
